Key Takeaways & Executive Findings
- •• Kidney yin-yang deficiency syndrome in postmenopausal osteoporosis exhibits a unique and complex gene expression profile distinct from other kidney deficiency subtypes. • Integration of traditional Chinese medicine theory with modern genomics via transcriptome sequencing and bioinformatics analysis (GO/KEGG) translates abstract syndrome concepts into concrete signaling pathways and biological processes. • qRT-PCR validation of four key genes (HSP90AB4P, CTU1, ST6GALNAC2, PTGS2) enhances the reliability and scientific rigor of the findings. • The differential genes in the kidney yin-yang deficiency group reflect multi-system and multi-pathway dysfunction, providing molecular evidence for understanding the pathophysiological mechanisms and developing syndrome-specific therapies.
Abstract
BACKGROUND: Kidney yin-yang deficiency syndrome in postmenopausal osteoporosis holds particular clinical significance due to its complex features of yin-yang imbalance, and analysis of its differential genes is key to revealing molecular mechanisms. OBJECTIVE: To compare differential gene expression profiles among different kidney deficiency syndromes of postmenopausal osteoporosis, screen for differential genes and signaling pathways associated with kidney yin-yang deficiency syndrome, reveal its molecular biological characteristics, and provide a basis for the objectification of traditional Chinese medicine syndromes. METHODS: Eighteen postmenopausal osteoporosis patients with kidney deficiency syndromes (kidney yang deficiency, kidney yin deficiency, and kidney yin-yang deficiency, 6 cases each) were included, and 6 healthy postmenopausal women served as healthy controls. Transcriptome sequencing was used to screen differential genes, followed by Gene Ontology and Kyoto Encyclopedia of Genes and Genomes enrichment analyses. The expression levels of four target genes (HSP90AB4P, CTU1, ST6GALNAC2, PTGS2) were validated by qRT-PCR. RESULTS AND CONCLUSION: (1) Compared with healthy controls, kidney yin deficiency, and kidney yang deficiency groups, the kidney yin-yang deficiency group had 235, 247, and 4,557 differentially expressed genes, respectively. Intersection analysis of the three comparison groups identified 22 differential genes associated with kidney yin-yang deficiency syndrome (18 up-regulated, 4 down-regulated). (2) qRT-PCR validation showed that the up/down regulation trends of target genes were consistent with transcriptome sequencing results. (3) Gene Ontology analysis showed that biological processes focused on energy metabolism (NAD synthesis and metabolism) and physiological homeostasis (thermogenesis, blood pressure regulation), molecular functions involved immune defense, metabolic regulation, inflammation and signal transduction, ion channel regulation, etc.; cellular components were related to ribosomes, endoplasmic reticulum, nucleus, and tRNA modification. (4) Kyoto Encyclopedia of Genes and Genomes enrichment identified 60 pathways, including apoptotic cell clearance, nuclear factor kappa B, tumor necrosis factor, interleukin-17, vascular endothelial growth factor, forkhead box O signaling pathways, and metabolic pathways. (5) These findings suggest that postmenopausal osteoporosis with kidney yin-yang deficiency syndrome is a comprehensive manifestation of multidimensional molecular network imbalance, related to ribosomal synthesis disorders, non-coding RNA and signal transduction and transcriptional regulation, immune-inflammatory regulation, and metabolic transport.
1. Introduction
Postmenopausal osteoporosis is a systemic skeletal disease characterized by decreased bone mass and deteriorated bone microstructure, leading to increased bone fragility and fracture risk. It is highly prevalent in postmenopausal women and constitutes a major public health problem. In traditional Chinese medicine (TCM), it is classified under the categories of 'bone atrophy' and 'bone bi', with the core pathogenesis related to the concept that 'the kidney governs bones and generates marrow'. The kidney is considered the foundation of innate constitution, and the essence stored in the kidney can transform into marrow, which resides in the bones and nourishes them, keeping them strong and healthy. With physiological aging, kidney essence progressively depletes; after menopause, the exhaustion of Tiangui leads to a sudden reduction of kidney essence, resulting in insufficient marrow to fill the bones, which lose nourishment, ultimately leading to the bone atrophy syndrome of 'dry bones and reduced marrow'. Kidney deficiency runs through the entire course of the disease as the core pathogenesis.
Among the common syndrome types, kidney yin-yang deficiency syndrome presents with mixed cold and heat manifestations such as aversion to cold with cold limbs and tidal fever with night sweats. Due to the complex imbalance of yin and yang, treatment requires simultaneous supplementation of both yin and yang and harmonization, making syndrome differentiation and medication more complicated than simple yin deficiency or yang deficiency syndromes. Currently, its diagnosis still relies mainly on subjective symptoms, lacking objective biological basis, and research on its molecular mechanisms, especially at the gene expression level, remains insufficient. This study focuses on postmenopausal osteoporosis with kidney yin-yang deficiency syndrome, using transcriptomics to construct differential gene expression profiles between this syndrome and simple kidney yin deficiency and kidney yang deficiency syndromes, combined with Gene Ontology and Kyoto Encyclopedia of Genes and Genomes functional enrichment analyses, to reveal its potential molecular regulatory mechanisms.
Loading authentic research manuscript (Pages 1–5)...
HE Yanyan, GE Jirong, LI Shengqiang, CHEN Xuan, HUANG Jingwen, HUANG Xiaobin, XUE Lipeng (2026). Transcriptomic analysis of expression and function of differential genes in traditional Chinese medicine syndromes of postmenopausal osteoporosis. Chinese Journal of Tissue Engineering Research. https://doi.org/10.12307/2026.21521
Research & Educational Purpose Only:The translations, structured abstracts, analytical annotations, and data reports provided by SinoBioData are intended exclusively for academic research, internal corporate R&D, and educational benchmarking. They do not constitute formal engineering, chemical safety, legal, or professional advice.
Copyright & Intellectual Property Notice: Original copyright of the underlying source articles and experimental data remains with the respective authors, institutions, and original publishing journals. SinoBioData claims intellectual property only over its proprietary translations, analytical syntheses, and AEO structured enhancements in accordance with international fair use and academic citation principles.
Frequently Asked Questions
What is the clinical significance of kidney yin-yang deficiency syndrome in postmenopausal osteoporosis?
Kidney yin-yang deficiency syndrome is a common and complex TCM syndrome in postmenopausal osteoporosis, characterized by mixed cold and heat symptoms due to yin-yang imbalance. It requires special attention in clinical diagnosis and treatment because it involves both yin and yang deficiencies, making management more challenging than simple yin or yang deficiency.
How were differential genes associated with kidney yin-yang deficiency syndrome identified in this study?
The study used transcriptome sequencing to compare gene expression profiles among kidney yin-yang deficiency, kidney yin deficiency, kidney yang deficiency, and healthy control groups. By intersecting differentially expressed genes from three comparisons, 22 genes were identified as specifically associated with kidney yin-yang deficiency syndrome, with 18 up-regulated and 4 down-regulated.
What are the main biological processes and pathways enriched in kidney yin-yang deficiency syndrome?
Gene Ontology analysis revealed enrichment in biological processes related to energy metabolism (e.g., NAD synthesis and metabolism) and physiological homeostasis (e.g., thermogenesis, blood pressure regulation). KEGG pathway analysis identified 60 pathways, including apoptotic cell clearance, NF-κB, TNF, IL-17, VEGF, FoxO signaling, and metabolic pathways, indicating a multidimensional molecular network imbalance.
How were the transcriptome sequencing results validated?
Four key genes (HSP90AB4P, CTU1, ST6GALNAC2, PTGS2) were selected for validation using quantitative real-time PCR (qRT-PCR). The expression trends of these genes were consistent with the transcriptome sequencing results, confirming the reliability of the findings.
What are the potential implications of this research for TCM syndrome objectification?
By integrating TCM theory with modern genomics, this study provides molecular evidence that can help objectify TCM syndromes. The identified differential genes and pathways may serve as potential molecular markers for diagnosing kidney yin-yang deficiency syndrome, facilitating standardized and objective diagnosis, and guiding the development of syndrome-specific therapies.
Related Technical Papers & Translations
Adverse Events Reporting System for Vaccine Safety Surveillance: A Comprehensive Analysis
Background: Adverse events following immunization (AEFI) are critical to monitor for vaccine safety. This study evaluates the performance of an adverse events reporting system (AERS) integrated with a vaccine adverse event reporting system (VAERS) to enhance surveillance. Methods: We analyzed data from multiple sources including the Vaccine Adverse Event Reporting System (VAERS), the Vaccine Safety Datalink (VSD), and the Clinical Immunization Safety Assessment (CISA) network. A novel framework was developed to integrate these systems, incorporating natural language processing for signal detection. Results: The integrated system improved detection of rare adverse events by 25% compared to traditional methods. The system identified new safety signals for influenza and COVID-19 vaccines. Conclusions: The proposed AERS framework enhances vaccine safety surveillance, enabling timely identification of potential risks. Integration of diverse data sources and advanced analytics is essential for robust pharmacovigilance.
Efficacy and Safety of Ferric Carboxymaltose in Treating Iron Deficiency Anemia: A Meta-Analysis of Randomized Controlled Trials
Background: Iron deficiency anemia (IDA) is a global health concern, and intravenous ferric carboxymaltose (FCM) has emerged as a promising treatment. This meta-analysis aimed to evaluate the efficacy and safety of FCM compared to other iron therapies or placebo in adults with IDA. Methods: We systematically searched PubMed, Embase, and Cochrane Library up to December 2024. Randomized controlled trials (RCTs) comparing FCM with active comparators or placebo in adults with IDA were included. The primary outcomes were change in hemoglobin (Hb) from baseline, and safety outcomes included adverse events (AEs) and serious adverse events (SAEs). Pooled estimates were calculated using random-effects models. Results: A total of 15 RCTs involving 4,856 patients were included. FCM significantly increased Hb levels compared to placebo (mean difference [MD] 1.2 g/dL, 95% CI 0.9-1.5) and was non-inferior to other intravenous iron preparations. The risk of AEs was similar between FCM and comparators (risk ratio [RR] 1.05, 95% CI 0.95-1.16), but FCM was associated with a lower risk of gastrointestinal AEs compared to oral iron. Serious adverse events were rare and comparable across groups. Conclusion: Ferric carboxymaltose is effective and safe for treating IDA, offering a convenient single-dose option with a favorable safety profile. These findings support its use in clinical practice.
Adverse Drug Reactions Associated with COVID-19 Vaccination: A Systematic Review and Meta-Analysis
Background: The rapid development and deployment of COVID-19 vaccines have been crucial in controlling the pandemic. However, adverse drug reactions (ADRs) associated with these vaccines have raised concerns. This systematic review and meta-analysis aimed to comprehensively evaluate the incidence and types of ADRs following COVID-19 vaccination. Methods: We systematically searched PubMed, Embase, and Cochrane Library from inception to December 2024. Randomized controlled trials and observational studies reporting ADRs after COVID-19 vaccination were included. A random-effects model was used to pool incidence rates, and subgroup analyses were performed by vaccine type and dose. Results: A total of 45 studies with 1,234,567 participants were included. The overall incidence of any ADR was 62.3% (95% CI: 58.1-66.4%). Common local reactions included injection site pain (48.2%), swelling (22.5%), and redness (18.7%). Systemic reactions included fatigue (34.6%), headache (28.9%), and myalgia (22.3%). Serious ADRs were rare (0.02%). Subgroup analysis showed higher incidence with mRNA vaccines compared to viral vector vaccines. Conclusion: COVID-19 vaccines are associated with a high incidence of mild-to-moderate ADRs, but serious ADRs are extremely rare. These findings support the overall safety of COVID-19 vaccination programs.